Bristol-Myers Squibb (BMY)

Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.

The Top 10 Stocks Helping Warren Buffett Beat the Market

By Patrick Sanders, InvestorPlace Contributor May 11, 2022

These Warren Buffett stocks are helping the Oracle of Omaha be a winner even in a down market. All are generating solid returns in 2022.

3 Recession-Proof Dividend Stocks to Buy

By Bob Ciura, Sure Dividend Apr 8, 2022

ABM Industries, Bristol-Myers and UGI are three examples of companies that saw earnings-per-share grow by high rates during the 2007 to 2009 period. All three companies have extensive dividend growth track records and each stock yields higher than what the S&P 500 is paying.

Best Stocks for 2022: Bristol-Myers Squibb Isn’t Done Growing

By Sure Dividend Apr 8, 2022

It's been a great year for Bristol-Myers Squibb this year, but it's not too late to jump in. BMY stock offers a respectable dividend.

7 Biotech Stocks to Buy With Key Catalysts for April

By Shanthi Rexaline Apr 5, 2022

Biotech stocks are very sensitive to some key catalysts such as the FDA decision date, aka PDUFA date, clinical readouts/presentations and Adcom meeting. The month of April will see some companies belonging to the sector seeing some of these make-or-break catalysts.

7 No-Brainer Stocks to Buy for April

By Chris Lau, InvestorPlace Contributor Apr 4, 2022

Start your stock scan with companies showing strong quant scores in value, growth and quality, then buy those with strong catalysts.

7 Michael Burry Stocks to Buy as ‘The Big Short’ Investor Makes Moves

By Thomas Niel, InvestorPlace Contributor Mar 17, 2022

The famed investor has largely cashed out of equities, but you may want to check out these 7 Michael Burry stocks still in his portfolio.

3 Top Stock Trades for This Week

By Tyler Craig, Tales of a Technician Mar 15, 2022

Bulls seeking stock trades should focus on relative strength. Here are three stocks itching for new highs as the market sinks.

7 Drug Stocks to Consider After the Viatris Plunge

By Thomas Niel, InvestorPlace Contributor Mar 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

8 Strong Uptrend Stocks to Buy on the Next Dip

By Bret Kenwell, InvestorPlace Contributor Mar 9, 2022

It's hard to believe, but there are uptrend stocks out there. Investors just have to look for the strength that these stocks are showing.

7 Biotech Stocks With Key Catalysts in March

By Shanthi Rexaline Mar 9, 2022

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

By Samuel O'Brient, InvestorPlace Reporter Feb 4, 2022

Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit.

3 Healthcare Stocks Ignoring the Market Mayhem

By Tyler Craig, Tales of a Technician Jan 19, 2022

Sellers dominate the Street this week, but some healthcare stocks remain unaffected. Here are three to put atop your watchlist.

10 Best Stocks for 2022: What’s on Tap for Wall Street This Year?

By Nick Clarkson, Web Editor Jan 14, 2022

With the new year underway on Wall Street, 10 InvestorPlace writers and analysts select their picks for the best stocks for 2022.

3 Top Stock Trades for the Week of Jan. 10, 2022

By Tyler Craig, Tales of a Technician Jan 10, 2022

Sellers continue to push their advantage making it necessary to play defense to win. Here are three top stock trades for the new week.

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

Best Stocks for 2022: Bristol-Myers Squibb Will Offer Huge Returns

By Sure Dividend Dec 30, 2021

Bristol-Myers Squibb offers a substantial dividend, but that's far from the only reason that BMY stock is a great investment for 2022.

7 Drug Stocks to Buy Now While They’re Still on Sale

By Chris Lau, InvestorPlace Contributor Nov 30, 2021

Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.

Bristol-Myers Squibb (BMY)

Best Stocks for 2022: After Two Quarters, Who Holds The Lead?

Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year

6 Stocks Hedge Funds Love in a Recession

5 S&P 500 Stocks Ready to Break Out

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Bristol-Myers Squibb (BMY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BMY Stock Predictions, Articles, and Bristol-Myers Squibb News

Subscriber Sign in